Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Geretti

Showing results (71-80 of 175) with videos related to

Pageof 18
Sort By:
Plos Neglected Tropical Diseases|August 7, 2018
A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent actionJolynne Mokaya, Anna L McNaughton, Martin J Hadley, et al.
The Journal of Infectious Diseases|January 6, 2007
Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapyMeghna Ramaswamy, Anele Waters, Colette Smith, et al.
Antiviral Therapy|October 9, 2008
Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitorsDavid Dunn, Anna Maria Geretti, Hannah Green, et al.
Journal of Clinical Microbiology|July 16, 2010
Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in GhanaAnna Maria Geretti, Mauli Patel, Fred Stephen Sarfo, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2013
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenzAnna Maria Geretti, Tim Conibear, Andrew Hill, et al.
Infectious Diseases and Therapy|August 1, 2022
HIV DNA Sequencing to Detect Archived Antiretroviral Drug ResistanceAnna Maria Geretti, Jose Luis Blanco, Anne Genevieve Marcelin, et al.
AIDS (London, England)|November 21, 2002
Primary antiretroviral resistance in newly diagnosed patients with established heterosexually acquired HIV-1Anna Maria Geretti, Melvyn Smith, Ceri Watson, et al.
Sexually Transmitted Infections|May 10, 2022
Sexual transmission of infections across Europe: appraising the present, scoping the futureAnna Maria Geretti, Otilia Mardh, Henry J C de Vries, et al.
Antiviral Research|March 29, 2011
Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experienceCarolina Garrido, Vincent Soriano, Anna Maria Geretti, et al.
Journal of Medical Virology|August 21, 2007
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected personsGaia Nebbia, Ana Garcia-Diaz, Ursula Ayliffe, et al.
Pageof 18

Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Plos Neglected Tropical Diseases|August 7, 2018
A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent actionJolynne Mokaya, Anna L McNaughton, Martin J Hadley, et al.
The Journal of Infectious Diseases|January 6, 2007
Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapyMeghna Ramaswamy, Anele Waters, Colette Smith, et al.
Antiviral Therapy|October 9, 2008
Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitorsDavid Dunn, Anna Maria Geretti, Hannah Green, et al.
Journal of Clinical Microbiology|July 16, 2010
Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in GhanaAnna Maria Geretti, Mauli Patel, Fred Stephen Sarfo, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2013
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenzAnna Maria Geretti, Tim Conibear, Andrew Hill, et al.
Infectious Diseases and Therapy|August 1, 2022
HIV DNA Sequencing to Detect Archived Antiretroviral Drug ResistanceAnna Maria Geretti, Jose Luis Blanco, Anne Genevieve Marcelin, et al.
AIDS (London, England)|November 21, 2002
Primary antiretroviral resistance in newly diagnosed patients with established heterosexually acquired HIV-1Anna Maria Geretti, Melvyn Smith, Ceri Watson, et al.
Sexually Transmitted Infections|May 10, 2022
Sexual transmission of infections across Europe: appraising the present, scoping the futureAnna Maria Geretti, Otilia Mardh, Henry J C de Vries, et al.
Antiviral Research|March 29, 2011
Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experienceCarolina Garrido, Vincent Soriano, Anna Maria Geretti, et al.
Journal of Medical Virology|August 21, 2007
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected personsGaia Nebbia, Ana Garcia-Diaz, Ursula Ayliffe, et al.
Pageof 18